Monday, August 16, 2021
Monday, August 16, 2021
Posted on 08/16/2021

CISD is committed to provide COVID-19 updated information and current status of active cases. We continuously revise the current public health guidelines and recommendations provided by the local, state and national health authorities including: Center for Disease Control and Prevention, Texas Education Agency, American Academy of Pediatrics, El Paso Department of Health and Texas Department of State Health Services to accommodate our protocols as needed to ensure the safety and overall wellbeing of all our students and staff.

Positive Cases on CISD Community

On CISD schools, there were a total of 8 positive laboratory confirmed COVID-19 cases on staff or students reported during the week of August 9 to August 15, 2021 (Table 1). Out of the 8 positive COVID-19 cases reported this week among our CISD staff and student population, all 8 cases (100%) were individuals who are unvaccinated and all 8 cases were identified as students (100%).

Table 1. Total number of weekly positive laboratory confirmed cases and accumulated cases on CISD Schools for the 2021-2022 school year.

CISD School New Cases Reported* Accumulated Cases
Week Aug. 9 - Aug. 15 As of Aug. 15, 2021
  Canutillo HS 0 3
  Northwest ECHS 0 1
  Canutillo MS 0 2
  Alderete MS 2 2
  Canutillo ES 0 1
  Deanna Davenport ES 2 2
  Jose Damian ES 0 1
  Bill Childress ES 0 0
  Garcia ES 1 1
  Reyes ES 3 6
TOTAL  8 19

*Cases included in this report are those that have been confirmed and provided a copy of a COVID-19 positive laboratory report AND a report has been submitted to the El Paso Department of Public Health. Cases that are currently under investigati0n or have not provided a copy of a positive test result are not included but isolation/quarantine protocols have been initiated.

Table of reported cases

Fig. 1. Total number of cases (N=19) reported per week since July 19th to August 15th, of 2021.

As of August 15th, out of the 19 positive COVID-19 cases (N=19) reported since July 19th among our CISD staff and student population (Fig. 1), a total of 15 cases (78.9%) were among unvaccinated and 4 were among vaccinated individuals (21.1%); 14 cases were students (73.7%) and 5 were employees (26.3%).

Vaccinated vs. Unvaccinated

Fig. 2. Percentage rates of vaccinated vs. unvaccinated and student vs employees identified on accumulated COVID-19 cases (N=19) since July 19th to August 15t, of 2021.

City of El Paso Epidemiological Update: Current Cases & Stage Level for Week August 9 – August 15, 2021

According to the statistical report of the City of El Paso, as of August 16, 2021, there are currently a total of 15 active cases reported on the areas of Canutillo and Vinton. Our community is located under Stage 3 on the COVID-19 Community Scorecard with a (7-day average) positivity rate of 4.12% (City of El Paso, 2021). Further information at

Vaccination Rates in El Paso, Texas

Vaccination rates continue to increase. A total of 488,912 persons have been fully vaccinated in El Paso, TX. Percentage of population >12 fully vaccinated is 71.14% Full information at epstrong: and Texas Health and Human Services:

COVID-19 Breakthrough Cases in El Paso, Texas

As of August 16, there are currently 1,174 breakthrough cases reported in El Paso, TX.

U.S. Food & Drug Administration (FDA) (8/12/2021):

On August 12th, the U.S. Food and Drug Administration amended the emergency used authorizations (EUAs) for both the Pfizer-BioNTech COVID-19 Vaccine and the Moderna COVID-19 Vaccine to allow for use of additional dose in certain immunocompromised individuals, specifically, solid organ transplant recipients or those who are diagnosed with conditions that are considered to have an equivalent level of immunocompromise. Full press release at:

CDC Summary of recent changes regarding additional COVID-19 doses (8/13/2021):

On August 13, 2021, the Advisory Committee on Immunization Practices (ACIP’s) met and reviewed the data for use of an additional dose of mRNA COVID-19 vaccine for immunocompromised people within the Evidence to Recommendation Framework. ACIP made an interim recommendation for use of an additional dose of Pfizer-BioNTech COVID-19 vaccine (for persons aged ≥12 years) or Moderna COVID-19 vaccine (for persons aged ≥18 years) after an initial 2-dose primary mRNA COVID-19 vaccine series for moderately to severely immunocompromised people. The clinical considerations for use of an additional dose of an mRNA COVID-19 vaccine apply only to people who are moderately or severely immunocompromised. Full report here:

CDC Weekly Review (8/13/2021)

According to the Centers for Disease Control and Prevention: COVID-19 cases, hospitalizations and deaths continue to increase, especially in areas with higher levels of community transmission and lower vaccination coverage. Pediatric cases and hospitalizations have also increased in recent weeks. Although rates of COVID-19-associated hospitalizations are lower in children of all ages compared to adults, some children develop acute COVID-19 requiring hospitalization. In addition, some children who have COVID-19 may later develop Multisystem Inflammatory Syndrome in Children (MIS-C), a rare but serious condition associated with COVID-19. As of July 30, more than 4,400 children in the United States who have been diagnosed with COVID-19-associated MIS-C. Full information:

Further reading recommendations:

Please contact Dr. Maria Fuentes at 877-7670 (CISD Office at SSS) or email at for further information.